Stay updated with breaking news from Ian Horobin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Photo: UCL website. Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial intelligence and drug-discovery software to improve medical development for patients with cancer and inflammatory diseases.
Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial
/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced...
/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced...